These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 24228117)

  • 1. Loss of RhoGDI is a novel independent prognostic factor in hepatocellular carcinoma.
    Li W; Wang H; Jin X; Zhao L
    Int J Clin Exp Pathol; 2013; 6(11):2535-41. PubMed ID: 24228117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of RhoGDI, a novel predictor of distant metastasis, promotes cell proliferation and migration in hepatocellular carcinoma.
    Wang H; Wang B; Liao Q; An H; Li W; Jin X; Cui S; Zhao L
    FEBS Lett; 2014 Jan; 588(3):503-8. PubMed ID: 24374343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DLC-1 is an independent prognostic marker and potential therapeutic target in hepatocellular cancer.
    Song LJ; Liu Q; Meng XR; Li ShL; Wang LX; Fan QX; Xuan XY
    Diagn Pathol; 2016 Feb; 11():19. PubMed ID: 26846339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of hepatic Wnt5a and its clinicopathological features in patients with hepatocellular carcinoma.
    Wang L; Yao M; Fang M; Zheng WJ; Dong ZZ; Pan LH; Zhang HJ; Yao DF
    Hepatobiliary Pancreat Dis Int; 2018 Jun; 17(3):227-232. PubMed ID: 29709351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of ARHGDIA expression is associated with poor prognosis in HCC and promotes invasion and metastasis of HCC cells.
    Liang L; Li Q; Huang LY; Li DW; Wang YW; Li XX; Cai SJ
    Int J Oncol; 2014 Aug; 45(2):659-66. PubMed ID: 24859471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L1 cell adhesion molecule overexpression in hepatocellular carcinoma associates with advanced tumor progression and poor patient survival.
    Guo X; Xiong L; Zou L; Sun T; Zhang J; Li H; Peng R; Zhao J
    Diagn Pathol; 2012 Aug; 7():96. PubMed ID: 22888955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of beclin-1, an autophagic gene, in hepatocellular carcinoma associated with clinical pathological and prognostic significance.
    Qiu DM; Wang GL; Chen L; Xu YY; He S; Cao XL; Qin J; Zhou JM; Zhang YX; E Q
    BMC Cancer; 2014 May; 14():327. PubMed ID: 24885292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of somatostatin receptor 2 and 5 expression in operable hepatocellular carcinomas.
    Li S; Liu Y; Shen Z
    Hepatogastroenterology; 2012 Oct; 59(119):2054-8. PubMed ID: 22640914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic Wnt3a expression as an estimable prognostic marker for hepatocellular carcinoma.
    Pan LH; Yao M; Cai Y; Gu JJ; Yang XL; Wang L; Yao DF
    World J Gastroenterol; 2016 Apr; 22(14):3829-36. PubMed ID: 27076768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of SALL4 in the development and prognosis of hepatocellular carcinoma.
    Yin F; Han X; Yao SK; Wang XL; Yang HC
    World J Gastroenterol; 2016 Mar; 22(9):2837-43. PubMed ID: 26973422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of claudin 10 protein in hepatocellular carcinoma: impact on survival.
    Huang GW; Ding X; Chen SL; Zeng L
    J Cancer Res Clin Oncol; 2011 Aug; 137(8):1213-8. PubMed ID: 21647678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Notch1 and Notch4 are markers for poor prognosis of hepatocellular carcinoma.
    Ahn S; Hyeon J; Park CK
    Hepatobiliary Pancreat Dis Int; 2013 Jun; 12(3):286-94. PubMed ID: 23742774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The prognostic analysis of hepatocellular carcinoma based on the tumor neo-vessels, macrophages and α-SMA in tumor microenvironment].
    Fang M; Yuan JP; Liu LL; Cheng GP; Ying HJ; Chen YM; Chen M
    Zhonghua Zhong Liu Za Zhi; 2017 Jul; 39(7):518-523. PubMed ID: 28728298
    [No Abstract]   [Full Text] [Related]  

  • 15. High level of intercellular adhesion molecule-1 affects prognosis of patients with hepatocellular carcinoma.
    Zhu PP; Yuan SG; Liao Y; Qin LL; Liao WJ
    World J Gastroenterol; 2015 Jun; 21(23):7254-63. PubMed ID: 26109813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of cytoskeleton-associated membrane protein 4 and its palmitoyl acyltransferase DHHC2 in hepatocellular carcinoma.
    Li SX; Tang GS; Zhou DX; Pan YF; Tan YX; Zhang J; Zhang B; Ding ZW; Liu LJ; Jiang TY; Hu HP; Dong LW; Wang HY
    Cancer; 2014 May; 120(10):1520-31. PubMed ID: 24863391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression of a tumor suppressor gene JDP2 and its prognostic value in hepatocellular carcinoma patients.
    Chen YL; Chan SH; Lin PY; Chu PY
    Hum Pathol; 2017 May; 63():212-216. PubMed ID: 28315425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythropoietin and erythropoietin receptor in hepatocellular carcinoma: correlation with vasculogenic mimicry and poor prognosis.
    Yang Z; Sun B; Zhao X; Shao B; An J; Gu Q; Wang Y; Dong X; Zhang Y; Qiu Z
    Int J Clin Exp Pathol; 2015; 8(4):4033-43. PubMed ID: 26097591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of Rho GDP-dissociation inhibitor alpha is associated with tumor progression and poor prognosis of colorectal cancer.
    Zhao L; Wang H; Li J; Liu Y; Ding Y
    J Proteome Res; 2008 Sep; 7(9):3994-4003. PubMed ID: 18651761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
    Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
    World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.